February 2019

 

In this Supplement

Looking at the Full Scope of PAD

Cases, Techniques, and Economic Considerations for Complex Disease.

Issue

Supplement

Download a PDF of this supplement

Current Challenges for the Modern Management of PAD

An overview of contemporary and emerging practices in peripheral artery disease.

By Fanny S. Alie-Cusson, MD; and Jean M. Panneton, MD, FRCSC, FACS

Case Report: Treating a Long Chronic Total Occlusion in a Patient With CLI

A personalized treatment approach to a challenging case.

By Erik Weekman, BS; Vinayak Subramanian, BS; Ivy Smith, BS; and George L. Adams, MD, MHS, FACC, FSCAI

Treatment Challenges for Femoropopliteal Lesions

Discussion on managing complex peripheral artery disease, particularly in the femoropopliteal region, and a relevant case study to highlight specific challenges.

With M. Casey Becker, MD, FACC, FSCAI, FSVM

Case Report: Aortoiliac Occlusion in a Patient With Severe Claudication

Management with covered balloon-expandable stents provides another option for complex disease.

By Ehrin J. Armstrong, MD, MSc

Best Practices for Lower Extremity Bypass

Surgical and endoluminal treatment considerations for femoropopliteal lesions.

With Russell H. Samson, MD, FACS, RVT, DFSVS

Stenting Lesions in Distal Anatomy

Perspective on a modern-day treatment algorithm.

With Martin Werner, MD

A Physician Perspective on Collaborating With Your Hospital’s Value Analysis Committee

Speaking with a physician leader at Atrium Health’s Sanger Heart and Vascular Institute about advocating for physician device preferences and effectively communicating with key stakeholders.

With Frank R. Arko III, MD
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.